Диссертация (1174368), страница 21
Текст из файла (страница 21)
Miller // Ann. N.V. Acad. Sei. – 1975. - V.249. - P.9-26.175. Miller, L.S. TGF-alpha regulates TLR expression and function on epidermalkeratinocytes / L.S. Miller, O.E. Sorensen, P.T. Liu, H.R. Jalian // J. Immunol. –2005. – V.174 - N. 10 – P. 6137—6143.176. Miller, L.S.
Toll-like receptors in skin / L.S. Miller // Adv. Dermatol. – 2008.– V.24 – P. 71—87.177. Moore, M.M. Severe, generalized nummular eczema secondary to interferonalfa-2b plus ribavirin combination therapy in a patient with chronic hepatitis Cvirus infection / M.M. Moore, D.J. Elpern, D.J. Carter // Arch. Dermatol. – 2004.– V.140. – N.2. – P. 215-217.178. Naumann, A.
Сomprehensive analysis of the COL29A1 gene does not supporta role in eczema / A. Naumann, C. Sцderhдll, R. Fцlster-Holst, H. Baurecht, V.Harde, K. Mьller-Wehling, E. Rodrнguez, A. Ruether, A. Franke, S. Wagenpfeil,N. Novak, M. Mempel, B.N. Kalali, M. Allgaeuer, J. Koch, M. Gerhard, E. Melйn,C. Wahlgren, I.
Kull, C. Stahl, G. Pershagen, R. Lauener R, J. Riedler, G. Doekes,A. Scheynius, T. Illig, E. von Mutius, S. Schreiber, J. Kere, M. Kabesch, S. A.Weidinger // J. Allergy Clin. Immunol. – 2011. –V.24. – P. 139 -`144179. Niedner, R. Diagnosis of eczema. Can you recognize what your patient'ssymptom? / R. Niedner, D. Iliev // Fortschr. Med. – 2001. – V.14 - N.24. –P. 3033.180. Okenfels, N.M. Ethanol enhances the IFN-y, TGF- alpha and IL-6 secretionin psoriatic co-cultures / N.M.
Okenfels, C. Keim-Maas, R. Funk// Br. J.Dermatol. - 1996. - V.135. – N.5 - P. 746-751.181. Peterson, R.K. The key role of peptidogly-can in the opsonisation ofStaphilococcus aureus / R.K. Peterson, B.J. Wilkinson, G. Kim, D.Schmeling // J.Clin. Invest. – 1978. - V. 61. - P.
597-609.133182. Rietschel, R.L. Nonathopic eczemas /R.L. Rietschel // J. Am. Acad. Dermatol.– 1988. – V.18. – N.3. – P. 569 - 573.183. Robert, J. Eczema and hyper IgE. Effect of cephalosporins /J. Robert //Allerg. Immunol. – 1988. – V.20. – N.3. – P. 87-90.184. Ryu, Y.J. Toll-like receptor 2 polymorphisms and nontuberculousmycobacterial lung diseases / Y.J. Ryu, E.J.
Kim, W.J Koh // Clin. VaccineImmunol. - 2006. – N. 13. - P. 818-8191.185. Saint-Mezard, P. Afferent and efferent phases of allergic contact dermatitis(ACD) can be induced after a single skin contact with haptens: evidence using amouse model of primary ACD /P. Saint-Mezard, M. Krasteva, C. Chavagnac, S.Bosset, H. Akiba, J. Kehren, J.
Kanitakis, D. Kaiserlian, J.F. Nicolas // J. Invest.Dermatol. – 2003. – V.120. – N.4. – P.641-647.186. Sato, A. Dual recognition of herpes simplex viruses by TLR2 and TLR9 indendritic cells / A. Sato, M.M. Linehan, A. Iwasaki // Proc. Natl. Acad. Sci.
USA.– 2006. – V.103. – N. 46 0. - P.17343—17348.187. Satoh, T. Chronic nodular prurigo associated with nummular eczema: possibleinvolvement of odontogenic infection / T. Satoh, K. Takayama, Y. Sawada, H.Yokozeki, K. Nishioka // Acta Derm. Venereol. – 2003. – V.83. – N.5. – P. 376 –377.188. Schena, D. Sensitizing potential of triclosan and triclosan-based skin careproducts in patients with chronic eczema /D. Schena, A. Papagrigoraki, G.Girolomoni // Dermatol. Ther. – 2008.
– V.21 Suppl 2. – P.35-38.189. Schnyder, B. Mechanisms of drug-induced allergy /B. Schnyder, W.J. Pichler// Mayo Clin. Proc. – 2009. – V.84. – N.3. – P.268 - 272190. Simpson, C.R. Coincidence of immune-mediated diseases driven by Th1 andTh2 subsets suggests a common aetiology. A population-based study usingcomputerized general practice data / C.R. Simpson, W.J. Anderson, M.W.
Taylor,L. Watson, G.J. Prescott, D.J. Godden, R.N. Barker // Clin. Exp. Allergy – 2002.– V.32. –N.1. – P. 37 - 42.191. Simpson, C.R. "Trends in the epidemiology and prescribing of medication for134eczema in England" / C.R. Simpson, J.
Newton, J. Hippisley - Cox, A. Sheikh //Journal of the Royal Society of Medicine. – 2009. – V.102. – N.3. – P. 108–117192. Solomon, L.M. Eczema / L.M. Solomon // Dermatology. – 1984. – P. 361 366.193. Spirig, W. Current eczema therapy /W. Spirig, P.
Elsner // Schweiz RundschMed Prax. – 1994. – V.7. – N.83. – P. 718 - 721.194. Sticherling, M. Psoriasis capitis and seborrhoic eczema of scalp diseases /M.Sticherling // Hautarzt. – 2017. – V.68. – N.6 - P.457-465.195. Strauss, T. Endogenous eczema criteria for classification / T. Strauss // Z.Hautkr. – 1987. – V.62. – N.6.
– P. 427-29.196. Tanaka, T. Dental infection associated with nummular eczema as anoverlooked focal infection /T. Tanaka, T. Satoh, H. Yokozeki // J. Dermatol. –2009. – V.36. – N.8. – P. 462 - 465.197. Thomas, K. Multicentre randomised controlled trial and economic evaluationof ion-exchange water softeners for the treatment of eczema in children: theSoftened Water Eczema Trial (SWET) /K. Thomas, K. Koller, T.
Dean, C.O'Leary, T. Sach, A. Frost., J. Pallett, A. Crook, S. Meredith, A. Nunn, N.Burrows, I. Pollock, R. Graham-Brown, E. O'Toole, D. Potter, A. Williams //Health Technol. Assess. -2011. – V.15. – N..8 – P.1-156.198. Tenaud, I. In vitro modulation of TLR-2, CD1d and IL-10 by adapalene onnormal human skin and acne inflammatory lesion / L.
Tenaud, A. Khammari, B.Dreno // Exp. Dermatol. – 2007. – V.16. – N. 6 – p. 500 - 506.199. Van Zuuren, E.J. Emollients and moisturisers for eczema / E.J. Van Zuuren,Z. Fedorowicz, R. Christensen,A. Lavrijsen, B.W.M. Arents// CochraneDatabase Syst. Rev. – 2017. - b 6; 2: CD012119.200. Verbrugh, H.A. Antibodies to cell wall peptidoglycan of staphylococcusaureus in patients with serious staphylococcus infection / H.A. Verbrugh, R.Peters, M. Rozenberg-Arska , P.K. Peterson, J.
Verhoef// J. Inf. Dis. – 1981 -V.144. – N.1. - P. 1- 9.135201. Williams, H.C. Preventing eczema flares with topical corticosteroids ortacrolimus: which is best? / H.C. Williams // British Journal of Dermatology. –2011. - V. 164. – N. I2 - P. 231–261202. Zhang, D. A Toll-like receptor that prevent infection by uropathogenicbacteria / D. Zhang, G. Zhang, M.S. Hayden // Science.
- 2004. – V. 303(5663) –P. 1522–1526.136.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
